Masaru Mimura, MD, PhD

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

JCP
Machine Learning Prediction of ECT Responses
Original Research

August 24, 2022

Predicting individual therapeutic outcomes would be clinically useful to help patients accept electroconvulsive therapy (ECT) for treating depression. This study sought to develop a prediction model for ECT response...
Kazuki Nakajima, Akihiro Takamiya, Takahito Uchida, et al
JCP
Original Research

November 9, 2021

This study compared proportions of patients with comorbid psychiatric disorders among those hospitalized for either pulmonary embolism, a common cause of sudden cardiac arrest in psychiatric patients, or acute...
Kie Takahashi, Hiroyuki Uchida, Takefumi Suzuki, et al
JCP
Meta-Analysis

February 23, 2021

Single-daily-dose regimens are easier for patients to follow than multiple-dose regimens and may increase adherence. But do they work as well? And are they safe? Read this meta-analysis to...
Yuhei Kikuchi, Yutaro Shimomura, Takefumi Suzuki, et al
JCP
Review Article

July 28, 2020

Pharmacokinetics of antipsychotics are generally slower centrally than peripherally. This review examined the possible dissociation between central D2 receptor occupancy with antipsychotics and their peripheral blood concentrations.
Shin Kurose, Yu Mimura, Hiroyuki Uchida, et al
JCP
Original Research

February 11, 2020

Can overall response to antipsychotics be predicted by early improvements in individual symptoms among Alzheimer's disease patients? The current report analyzes the CATIE-AD phase 1 dataset in an attempt...
Tomoyuki Nagata, Shunichiro Shinagawa, Kazunari Yoshida, et al
JCP
Original Research

December 4, 2018

Poor treatment adherence masks the true extent of placebo effects in trials of antipsychotics in schizophrenia. Can use of an injectable placebo in double-blind trials of long-acting injectable antipsychotics...
Fumiaki Kumagai, Takefumi Suzuki, W. Wolfgang Fleischhacker, et al
JCP
Original Research

October 17, 2017

Placebo effects are a common obstacle in the search for Alzheimer's disease treatments. This analysis of data from the large CATIE-AD study investigates ways to screen out potential placebo...
Chisa Ozawa, Rachel Roberts, Kazunari Yoshida, et al
JCP
Original Research

February 28, 2017

Read a randomized control trial examining whether adding cognitive-behavioral therapy (CBT) for Pharmacotherapy-Resistant Depression improves outcomes.
Atsuo Nakagawa, Dai Mitsuda, Mitsuhiro Sado, et al
JCP
Article

February 22, 2017

A key to improving prognosis in bipolar depression may lie in analysis of specific symptoms. This reanalysis of the STEP-BD dataset provides clues to help you determine which patients...
Jin Mizushima, Hiroyuki Uchida, Mitsuhiro Tada, et al
JCP
Article

October 26, 2016

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out...
Hitoshi Sakurai, Takefumi Suzuki, Robert R. Bies, et al
JCP
Article

April 22, 2015

Fumihiko Ueno, Shinichiro Nakajima, Takefumi Suzuki, et al
JCP
Original Research

July 22, 2014

Hiroyoshi Takeuchi, Takefumi Suzuki, Robert R. Bies, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe